Clinical Trial Update: Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing rivaroxaban to standard of care in patients with Excessive Supraventricular Ectopies or Short Atrial Runs and high embolism r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Supraventricular Ectopies or Short Atrial Runs

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA) | Phase 4 | Status: NOT_YET_RECRUITING